Plan the move so you dont run out of medication mid-titration
Thats why so many women tell me, I lost the weight, but I dont feel strong or look how I expected. The good news
Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
NICE guidance (NG69) recommends specific psychological therapies, including enhanced CBT (CBT-E), for eating disorders
The medication's therapeutic effects depend on consistent administration and gradual dose escalation rather than the specific day of initiation
Anticipated Utilization Increases Expanded Eligibility: Coverage for obesity treatment could lead to a 40%60% increase in GLP-1 utilization over the first two years, with an estimated 1.52.5 million additional beneficiaries initiating therapy annually across Medicare and Medicaid